dorsaVi (DVL) Stock Price, News & Analysis

Company Overview

dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that analyzes how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes. It also offers ViPerform, a wearable and wireless movement sensor technology that offers objective data to assess risk of sport injury and guides athletic training and recovery programs; telehealth solutions; and professional suites. dorsaVi Ltd was incorporated in 2008 and is based in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$6.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DVL Stock Analysis - Frequently Asked Questions

How were dorsaVi's earnings last quarter?

dorsaVi Ltd (ASX:DVL) posted its quarterly earnings data on Thursday, February, 28th. The company reported ($0.01) EPS for the quarter. dorsaVi had a negative net margin of 95.66% and a negative trailing twelve-month return on equity of 102.89%.

What other stocks do shareholders of dorsaVi own?

Based on aggregate information from My MarketBeat watchlists, some other companies that dorsaVi investors own include Myriad Genetics (MYGN), VMware (VMW), Akers Biosciences (AKER), Alder Biopharmaceuticals (ALDR), Argos Therapeutics (ARGSQ), Aramark (ARMK) and Bellerophon Therapeutics (BLPH).

Company Calendar

• Last Earnings: 2/28/2019
• Today: 7/02/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Computer and Technology
• Industry: Scientific & Technical Instruments
• Sub-Industry: N/A
• Current Symbol: ASX:DVL
• CIK: N/A
• Web: www.dorsavi.com
• Phone: 1800 367 728
• Fax: N/A
• Employees: 34
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$1.25 million
• Net Margins: -95.66%
• Pretax Margin: N/A
• Return on Equity: -102.89%
• Return on Assets: -43.41%

Debt

• Debt-to-Equity Ratio: 18.58
• Current Ratio: 1.87
• Quick Ratio: 0.80

Sales & Book Value

• Annual Sales: A$1.30 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 1.71
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 669,780,000
• Free Float: N/A
• Market Cap: A$6.58 million
• Optionable: Not Optionable
• Beta: 1.24